Maddy reveals, what's there in his plate?

Maddy reveals, what's there in his plate?
Saturday, October 24, 2015 16:08 IST
By Santa Banta News Network
R. Madhavan has denied reports that he will play the negative role in the remake of Tamil blockbuster 'Thani Oruvan'. He says he has not 'signed or approved' any other film apart from forthcoming bilingual sport drama 'Saala Khadoos' ('Irrudhi Suttru' in Tamil).

Madhavan, who was earlier seen alongside Kangana Ranaut in 'Tanu Weds Manu Returns'`, took to Twitter on Friday to clarify the news.

In a series of tweets , Madhavan wrote: "Hey Folks.This being a verified site I shall personally tell you about the projects I have signed and doing. The rest are all rumours."

"I have not signed nor approved any other project in any language. Right now my life is only 'Saala Khadoos' and 'Irrudhi Suttru'."

Produced by filmmaker Rajkumar Hirani, 'Saala Khadoos', which marks the directorial debut of Sudha Kongara Prasad in the Hindi film industry, was earlier scheduled to release on October 16.

It is Madhavan's second movie with Hirani after "3 Idiots".
Sreeleela Pulled Into Crowd During Shoot With Kartik Aaryan - Real Scare or Reel Scene?

Bollywood Buzz: Kartik Aaryan and Sreeleela's Upcoming Film Sparks Viral Controversy

Monday, April 07, 2025
Rumours Debunked: Priyanka Chopra Not in Allu Arjun-Atlee Film!

In recent days, the internet has been abuzz with speculation about global icon Priyanka Chopra Jonas joining

Monday, April 07, 2025
Kapil Sharma Unveils New Poster of ‘Kis Kisko Pyaar Karoon 2’ on Ram Navami!

Kapil Sharma Celebrates Ram Navami with Glimpse of Upcoming Sequel Celebrating the auspicious occasion

Monday, April 07, 2025
Rashmika Mandanna Shares Heartwarming 'Dear Diary' Entry from Her Wholesome Birthday Celebration!

Popular actress Rashmika Mandanna, fondly known as the "National Crush," gave fans a peek into her

Monday, April 07, 2025
Urvashi Rautela Shuts Down Trolls with Grace, Embraces Bold New Avatar in 'Jaat'!

Actress Urvashi Rautela is no stranger to the spotlight—and sometimes, to the scrutiny that comes with

Monday, April 07, 2025
ADVERTISEMENT
ADVERTISEMENT